Our Company

At REVIAN, we're revolutionizing hair rejuvenation by harnessing the healing power of light. Our mission is to put the power to stop hair loss and regrow hair in the palm of your hand by utilizing the most advanced light science and clinically proven technology, all managed through an intuitive mobile app and convenient home-based treatment protocol.

A KnowBio LLC Subsidiary

Morrisville, North Carolina

Our Team

John Oakley

Chief Executive Officer and Director

With a 30-year career focused on scaling businesses, John Oakley has a distinguished history of leading companies through periods of rapid growth and success. His experience spans both public and private sectors, including roles at Flanders Corporation, Nexxus Lighting, Cleaver-Brooks, and Home Meridian International.

R.A. Lewis

General Manager

R.A. Lewis is an accomplished technology leader with over 20 years of expertise spanning technology innovation, mobile application development, and advanced systems architecture. His deep understanding of business intelligence and scaling strategies has driven significant growth, culminating in the successful acquisition of two companies.

Amy Keish

VP of Healthcare Sales

Amy Keish is a seasoned executive with a 19 year career in the hair restoration industry. Her skill set includes sales leadership, Provider relationships and healthcare operations, which she honed through strategic roles at Bosley and Hair Club, prior to joining Revian.

Doug Stevens

Director of Operations

Doug Stevens has over 30 years of experience in global supply chain management, manufacturing, and new product introduction. His deep expertise in optimizing supply chain processes and introducing innovative products has been developed in roles at Cree, Sony Ericsson and Roli prior to joining Revian.

Matt Womble

Director of Engineering

Matt Womble has over 19 years in the medical device industry, focusing on development of novel medical devices from concept to commercialization. His experience addressing clinical needs with simple, safe, and effective solutions was built through roles at Robling Medical, Baxano Surgical and 20/20 Technology prior to joining Revian.

Tammy Carrea

Vice President of Quality, Regulatory and Clinical Affairs

Tammy Carrea has over 30 years of experience in medical device development and commercialization, both domestically and internationally, and has been responsible for submissions and registrations for Class 1, 2, and 3 medical devices including De Novo and orphan devices. Her experience includes previous roles with Titan Medical, Baebies and TransEnterix prior to joining Revian’s parent company, KNOW Bio.

John Demos

General Counsel

John Demos has over 20 years of experience managing legal affairs and patent filing, licensing and litigation. His experience includes previous roles with Cree, Scenera and McNair Law Firm prior to joining Revian’s parent company, KNOW Bio.

Board of Directors

Neal Hunter

Chairman

Neal Hunter is a seasoned technology executive with a distinguished 30-year career building and scaling successful companies both in the public and private sectors. His entrepreneurial journey began as a co-founder of Cree, Inc. (NASDAQ:CREE), where he played a pivotal role in its growth and evolution. As CEO and Chairman from 1994 to 2001, and subsequently as Chairman until 2005. His expertise in guiding companies from inception to public market success is a testament to his strategic vision and leadership abilities. Neal Hunter served multiple roles at Cree, including as the public company CEO and Chairman from 1994 to 2001 and then Chairman until 2005.

Bill Saxelby

Director

Bill Saxelby has extensive expertise in the medical device industry including commercialization and strategy development driving growth and profitability for both public and private companies. During his 40 year career in the health sciences industry, he has held senior executive positions and served on Boards of Directors for companies including Landauer, Medical Research Laboratories, and Sunrise Medical.

Our History

REVIAN Inception

January 2016

REVIAN Clinical Trial

April 2017 - May 2019

REVIAN FDA Clearance (K173729)

February 28, 2018

REVIAN Launch

March 1, 2018

Patent No. US D849,959 (Phototherapy Cap)

May 28, 2019

Patent No. 10,525,275 (Phototherapeautic Modulation of Nitric Oxide)

January 7, 2020

MedTech Breakthrough Winner | Best New Technology Solution - Dermatology

May 2020

Patent No. 10,688,315 (Phototherapy Devices for Treatment of Dermatological Disorders of the Scalp)

June 23, 2020

1 million Treatments Completed

October 2020

Revian Physician Network Reaches 1,000 Providers

June 2021

Patent No. US D935,040 (Phototherapy Cap)

November 11, 2021

2 Million Treatments Completed

January 2022

Wake Forest University School of Medicine | Clinical Study Reveals Positive Outcome in Central Centrifugal Cicatricial Alopecia

June 2022

3 Million Treatments Completed

July 2023

Revian Physician Network Reaches 2,000 Providers

March 2024

REVIAN Presents Breakthrough Research on 74% Dihydrotesterone Reduction with Patented Dual Wavelength Technology

May 14, 2024

Worldwide Patent Sublicense Agreement Announced

July 11, 2024